Treatment of Chronic Inflammatory Demyelinating Polyradiculoneuropathy
February 27, 2012|Neurology
Author and Disclosure Information
A supplement to Clinical Neurology News. This supplement was supported by Talecris Biotherapeutics. |
|
|
Topics • Diagnosing CIDP • Therapeutic Options ,• The ICE Study • Best Practices: Key Takeaways Faculty/Faculty Disclosures Vera Bril, MD
Department of Neurology
University Health Network
Toronto, Ontario, Canada
Dr. Bril was a consultant with Talecris Biotherapeutics. Copyright © 2008 Elsevier Inc. To view the supplement, click the image above. |
